manufacturing cutting edge fluorescence immunoassay (FIA) solutions to enhance and progress quality healthcare access globally. In 2020, OptiBio was selected by a research fund sponsored by the Bill Melinda Gates foundation for its unique and dedicated approach to immunoassay. OptiBio's fundamental approach of integrating in-house capabilities allows OptiBio to constantly improve its product performance, customize its solutions based on client feedback, develop new test parameters, and respond to changing market needs. OptiBio will continue to create, improve, and innovate world class diagnostic solutions in the field of fluorescence immunoassay and point-of-care testing (POCT). Through this, we aim to ultimately transform medical diagnosis into a universally available right.
Optical Q CRP Immunoassay Test Kit
Product Details:
X
Optical Q CRP Immunoassay Test Kit Price And Quantity
- 1 Unit
Product Description
Product Description
Product Features
The Optical Q CRP diagnostic test is a proprietary point of care fluorescence immunoassay designed for prompt and accurate in-vitro quantitative measurement of CRP. The Optical Q CRP reagent test is a FIA test kit that does not require processing with a centrifuge, allowing for a. quicker results and b. higher accuracy.
Specification
Product Usage
C reactive protein is an acute reaction protein produced by the liver and is secreted into the bloodstream within a few hours after the onset of an infection or inflammation. As CRP increases in severe cases of inflammation, tests are done on the patients clinical symptoms or for patients at risk of acute inflammation post-surgery.
CRP tests are conducted to assist with conditions such as rheumatoid arthritis and lupus, and is often repeated to determine the efficacy of a treatment. CRP is also a useful test index for inflammatory reactions, and can be used for early detection of potential infections in wound healing and surgical resection, organ transplantation, and burn patients. Rapid diagnosis and treatment are essential in acute inflammatory reactions.
CRP tests are conducted to assist with conditions such as rheumatoid arthritis and lupus, and is often repeated to determine the efficacy of a treatment. CRP is also a useful test index for inflammatory reactions, and can be used for early detection of potential infections in wound healing and surgical resection, organ transplantation, and burn patients. Rapid diagnosis and treatment are essential in acute inflammatory reactions.
Company Profile
OptiBio Co., Ltd. is a South Korean in-vitro diagnostics (IVD) company focused in researching, developing, and
Enter Buying Requirement Details